After numerous fatalities due to a drug manufactured by Qiqihar No 2 Pharmaceutical Co Ltd, the Guangzhou People's Intermediate Court sentenced five of its employees to serve between four and seven years in prison for their roles in the outrage.
Thirteen deaths caused by kidney failure was the result following
administration of the drug at the Third Affiliated Hospital of
Guangzhou and sixty patients fell ill after taking the treatment in
2006, with the drug claiming its 14th life in January this year.
Relatives of the victims filed a law suit against Qiqihar No 2
Pharmaceutical Co Ltd, the Third Affiliated Hospital of Guangzhou Sun
Yat-sen University, Guangdong Health Care Goods Co, and Guangzhou
Jinhengyuan Medicine Trading Co, which the court believes each had a
hand in the deaths, were ordered to pay a combined RMB3.5m, media
reports.
The court ruled that between RMB7,100 and RMB660,000 should be paid to
the plaintiffs as compensation based on the degree to which they have
been affected by the drug. This will become effective in 18 days unless
an appeal is filed within 15 days of the ruling, the court said.
News & Interviews 
(0 vote)
